title: Ventricular arrhythmias, conclusion: new agents, additional treatment modalities, and overall approach to the problem.
abstract: In this final installment, we discuss use of the newer antiarrhythmic agents and indications for additional treatment modalities such as programmed electrophysiologic stimulation (PES), surgery, and implantation of the automatic cardioverter-defibrillator. We conclude with our approach for evaluating the efficacy of antiarrhythmic therapy.
authors.affiliation: University of Florida, College of Medicine, Gainesville.
authors.forename: K
authors.initials: K
authors.lastname: Grauer
authors.forename: J
authors.initials: J
authors.lastname: Gums
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000601:surgery; D006352:Heart Ventricles; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods
chemical_list: D000889:Anti-Arrhythmia Agents